Experience
Stryker Corporation
Genetics Institute
The PTO initiated an interference between a patent application of Finnegan client Genetics Institute and a patent of Stryker Corporation. The PTO awarded judgment to Genetics Institute, thus resolving priority of invention to the disputed subject matter. The interference related to bone morphogenic proteins, which affect bone growth.
Stryker Corporation v. Genetics Institute, Int. No. 105508, PTAB, Judges McKelvey, Nagumo, Schafer
Finnegan secures an award of priority in transdermal drug delivery interference
Minnesota Mining and Manufacturing Co.
Interference victory for inventors of electrosurgical scissors
Boston Scientific
Institut Pasteur
Resolving an appropriate standard for what Is “material” information in patent prosecution
Digital Control, Inc.
Alliance for Sustainable Energy, LLC
Geron Corp.
LG Electronics Inc.
Finnegan trade secret case resolved with favorable summary judgment for client RichWave
RichWave Technology Corporation
Abbott Vascular
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.